Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2
Oncology Today with Dr Neil Love
00:00
Sequencing T-DXd and re-biopsy at progression
Dr Janjigian recommends re-biopsy or ctDNA at progression and prefers T-DXd in second line for HER2 persistence.
Play episode from 14:58
Transcript
